MetLife, Inc.
MET · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $16,881,000 | $17,176,000 | $18,263,000 | $18,440,000 |
| % Growth | -1.7% | -6% | -1% | – |
| Cost of Goods Sold | $13,944,000 | $12,636,000 | $13,542,000 | $13,576,000 |
| Gross Profit | $2,937,000 | $4,540,000 | $4,721,000 | $4,864,000 |
| % Margin | 17.4% | 26.4% | 25.9% | 26.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,529,000 | $1,545,000 | $1,563,000 | $1,509,000 |
| SG&A Expenses | $1,529,000 | $1,545,000 | $1,563,000 | $1,509,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $198,000 | $2,015,000 | $1,804,000 | $1,974,000 |
| Operating Expenses | $1,727,000 | $3,560,000 | $3,367,000 | $3,483,000 |
| Operating Income | $1,210,000 | $980,000 | $1,354,000 | $1,381,000 |
| % Margin | 7.2% | 5.7% | 7.4% | 7.5% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $1,210,000 | $980,000 | $1,354,000 | $1,381,000 |
| Tax Expense | $308,000 | $245,000 | $404,000 | $106,000 |
| Net Income | $896,000 | $729,000 | $945,000 | $1,271,000 |
| % Margin | 5.3% | 4.2% | 5.2% | 6.9% |
| EPS | 1.23 | 1.04 | 1.29 | 1.79 |
| % Growth | 18.3% | -19.4% | -27.9% | – |
| EPS Diluted | 1.22 | 1.03 | 1.28 | 1.78 |
| Weighted Avg Shares Out | 664,700 | 670,800 | 682,300 | 696,067 |
| Weighted Avg Shares Out Dil | 669,100 | 675,000 | 687,000 | 697,900 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $271,000 | $269,000 | $258,000 | $259,000 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1,481,000 | $1,249,000 | $1,612,000 | $1,640,000 |
| % Margin | 8.8% | 7.3% | 8.8% | 8.9% |